Because of the COVID-19 pandemic, health systems now provide the majority of telehealth across the country. However, while health system physicians are going back to their office-based routine, patient demand in many cases has started to outstrip the health system supply.
Some health systems…
Source: Healthcareitnews.com and Read More
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
